United States · FDA National Drug Code directory
Tizanidine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55111-179_d469765b-0630-bbe2-6a19-56669a1f2107
- Product NDC
- 55111-179
- Form
- TABLET
- Composition / generic term
- Tizanidine
- Labeler
- Dr. Reddy's Laboratories Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20020703
- Source listing expiry
- 20271231
Source-listed ingredients
- TIZANIDINE HYDROCHLORIDE — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 300 TABLET in 1 BOTTLE (55111-179-03) · 55111-179-03
- 1000 TABLET in 1 BOTTLE (55111-179-10) · 55111-179-10
- 150 TABLET in 1 BOTTLE (55111-179-15) · 55111-179-15
- 30 TABLET in 1 BOTTLE (55111-179-30) · 55111-179-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →